Search
29/03/2025
The Spanish GIRO Guideline: A Paradigm Shift in the Management of Obesity in Adults
Lecube, A, Azriel, S, Barreiro, E, Blay, G, Carretero-Gómez, J, Ciudin, A, Fernández, JM, Flores, L, de Hollanda, A, Martínez, E, Miñambres, I, Moizé, V, Morales, C, Ramírez, V, Salvador, J, Soler, MJ, Supervía, M, Valenti, V, Vicente-Rodríguez, G, Vilarrasa, N, Malagón, MM. The Spanish GIRO Guideline: A Paradigm Shift in the Management of Obesity in Adults. Obesity Facts. 2025; 18(4)DOI:10.1159/000544880. PMID:40159422. IF:4.700(Q1/2D).
28/03/2025
Interindividual variability and its impact on the effectiveness of Janus kinase inhibitors in rheumatoid arthritis treatment
Martinez-Molina, C, Vidal, S, Diaz-Torne, C, Park, HS, Corominas, H. Interindividual variability and its impact on the effectiveness of Janus kinase inhibitors in rheumatoid arthritis treatment. Frontiers in Medicine. 2025; 12DOI:10.3389/fmed.2025.1512501. PMID:40224626. IF:3.000(Q1/2D).
28/03/2025
Beyond the status quo: when disease volume and metastatic timing are not enough to personalize treatment in mHSPC
Borque-Fernando, A, Alonso-Gordoa, T, Juan-Fita, MJ, Campos, FL, Pérez-Fentes, DA, Vilaseca, A, Agut, CM, Usán, P, Rey, PM. Beyond the status quo: when disease volume and metastatic timing are not enough to personalize treatment in mHSPC. Future Oncology. 2025; 21(8)DOI:10.1080/14796694.2025.2468569. PMID:40029138. IF:2.600(Q3/6D).
27/03/2025
Validation of the CAMCOG-DS-II, a neuropsychological test battery for Alzheimer's disease in people with Down syndrome: A Horizon 21 European Down syndrome Consortium study
Ivain, P, Baksh, A, Saini, F, Idris, M, Tamayo-Elizalde, M, Wells, J, Benejam, B, Loosli, SV, Sandkühle, K, Wlasich, E, Wagemann, O, Levin, J, Martet, D, Sacco, S, Falquero, S, Clert, M, Rebillat, AS, Khoo, WM, Smith, MA, Beresford-Webb, J, Zaman, S, Carmona-Iragui, M, Videla, L, Fortea, J, Langballe, EM, Medboen, IT, Larsen, FK, Baldimtsi, E, Paradisi, R, Ntailakis, P, Tsolaki, M, Papantoniou, G, Mcglinchey, E, Mccarron, M, Kennelly, S, Strydom, A. Validation of the CAMCOG-DS-II, a neuropsychological test battery for Alzheimer's disease in people with Down syndrome: A Horizon 21 European Down syndrome Consortium study. ALZHEIMERS & DEMENTIA. 2025; 21(3)DOI:10.1002/alz.70071. PMID:40145416. IF:11.100(Q1/1D).